We are live on ! Find out more
SS

SBI Securities Portfolio holdings

AUM $4.4B
1-Year Est. Return 74.25%
This Fund
S&P 500
This Quarter Est. Return
+47.72%
1 Year Est. Return
+74.25%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$4.4B
AUM Growth
+$748M
Cap. Flow
+$13.5M
Cap. Flow %
0.31%
Top 10 Hldgs %
40.7%
Holding
4,249
New
236
Increased
1,473
Reduced
1,489
Closed
152

Sector Composition

Rank Sector Weight
1 Technology 30.64%
2 Communication Services 6.61%
3 Consumer Discretionary 5.44%
4 Financials 3.65%
5 Industrials 2.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
APYX icon
3126
Apyx Medical
APYX
$161M
$368 ﹤0.01%
82
+72
+720% +$285
JOUT icon
3127
Johnson Outdoors
JOUT
$479M
$368 ﹤0.01%
8
METD
3128
Direxion Daily META Bear 1X ETF
METD
$8.38M
$368 ﹤0.01%
21
+19
+950% +$312
GSM icon
3129
FerroAtlántica
GSM
$626M
$366 ﹤0.01%
115
HUIZ
3130
Huize Holding Ltd
HUIZ
$12.2M
$365 ﹤0.01%
329
RUSHA icon
3131
Rush Enterprises Class A
RUSHA
$5.93B
$365 ﹤0.01%
5
+2
+67% +$141
AMBR
3132
Amber International Holding Ltd
AMBR
$131M
$365 ﹤0.01%
245
+12
+5% +$23
DMRA
3133
Damora Therapeutics, Inc. Ordinary Shares
DMRA
$1.8B
$364 ﹤0.01%
14
CATO icon
3134
Cato Corp
CATO
$65.3M
$363 ﹤0.01%
112
BBCP icon
3135
Concrete Pumping Holdings
BBCP
$550M
$362 ﹤0.01%
+30
New +$257
OESX icon
3136
Orion Energy Systems
OESX
$42.4M
$362 ﹤0.01%
31
CASS icon
3137
Cass Information Systems
CASS
$695M
$359 ﹤0.01%
+7
New +$332
MBIO icon
3138
Mustang Bio
MBIO
$4.32M
$357 ﹤0.01%
509
ACRS icon
3139
Aclaris Therapeutics
ACRS
$765M
$354 ﹤0.01%
67
REVB icon
3140
Revelation Biosciences
REVB
$4.18M
$354 ﹤0.01%
344
OTLK icon
3141
Outlook Therapeutics
OTLK
$247M
$353 ﹤0.01%
222
DRUG
3142
Bright Minds Biosciences
DRUG
$700M
$351 ﹤0.01%
5
ZAP
3143
Global X U.S. Electrification ETF
ZAP
$478M
$346 ﹤0.01%
+10
New +$337
DTST icon
3144
Data Storage Corp
DTST
$7.62M
$345 ﹤0.01%
100
TNGX icon
3145
Tango Therapeutics
TNGX
$4.47B
$344 ﹤0.01%
11
+10
+1,000% +$247
WGS icon
3146
GeneDx Holdings
WGS
$1.88B
$343 ﹤0.01%
5
-2
-29% -$114
ALRS icon
3147
Alerus Financial
ALRS
$808M
$342 ﹤0.01%
11
-1
-8% -$27
PLRX icon
3148
Pliant Therapeutics
PLRX
$66.9M
$342 ﹤0.01%
300
SBFM
3149
Sunshine Biopharma
SBFM
$3.63M
$340 ﹤0.01%
162
-21
-11% -$135
FWRD icon
3150
Forward Air
FWRD
$490M
$338 ﹤0.01%
25
+10
+67% +$149

Similar funds

SBI Securities's Q2 2026 Portfolio in Review

As of Q2 2026, SBI Securities held 4,249 positions worth $4.4B, up 21% from $3.65B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

SBI Securities's Q2 2026 filing shows 236 new, 1,473 increased, 1,489 reduced and 152 closed positions. Its largest new stake was Berkshire Hathaway Class B: 67,127 shares worth $33.6M. The largest sale was Direxion Daily Semiconductor Bull 3X ETF, an estimated $28.7M.

By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 28% a quarter earlier, followed by Communication Services and Consumer Discretionary.

  • SBI Securities's largest Q2 2026 buy was Berkshire Hathaway Class B: 67,127 shares worth $33.6M.
  • SBI Securities added most to VanEck Semiconductor ETF in Q2 2026, an estimated $32.5M increase.
  • SBI Securities's biggest Q2 2026 reduction was Direxion Daily Semiconductor Bull 3X ETF, cutting an estimated $28.7M.
  • SBI Securities fully exited GraniteShares 2x Long MARA Daily ETF in Q2 2026, selling an estimated $354K.
  • SBI Securities's ten largest holdings make up 41% of its $4.4B portfolio in Q2 2026.
  • SBI Securities opened 236 new positions and closed 152 in Q2 2026.
  • SBI Securities's portfolio value rose 21% quarter-over-quarter to $4.4B.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.